Cadonilimab, a PD-1/CTLA-4 bispecific antibody in unresectable hepatocellular carcinoma: a real-world study - Wang, Yilin; Pan, Shida; Tian, Jiahe; Wang, Jianing; Yu, Yingying; Wang, Siyu; Li, Fengyi; Yang, Luo; Liu, Xiaomeng; Shen, Yingjuan; Qiu, Qin; Luan, Junqing; et al. (Cancer Immunology, Immunotherapy, 2025)